Longwood Capital Partners »

Newamsterdam Pharma Co Nv shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.3M 50k 25.70
2024-06-30 $432k 23k 19.21

More positions owned by Longwood Capital Partners

Ocular Therapeutix (OCUL)
Cidara Therapeutics Com New (CDTX)
Tourmaline Bio (TRML)
Aadi Bioscience (WHWK)
Insmed Com Par $.01 (INSM)
Bright Minds Biosciences Com New (DRUG)
Argen Se - Sponsored Adr (ARGX)
Amylyx Pharmaceuticals (AMLX)
Terns Pharmaceuticals (TERN)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Compass Therapeutics (CMPX)
Praxis Precision Medicines I (PRAX)
Surrozen Com New (SRZN)
Ascendis Pha- Sponsored Adr (ASND)
Krystal Biotech (KRYS)

View all positions for Longwood Capital Partners

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Bain Capital Life Sciences Investors
RA Capital Management
Capital World Investors
Fcpm Iii Services B.v.
Viking Global Investors
FMR
Deerfield Management Company
Jennison Associates
Wellington Management Company
Polar Capital Holdings
Medicxi Ventures Management
Adage Capital Partners GP
Cormorant Asset Management
Alliancebernstein

View all funds holding Newamsterdam Pharma Co Nv